Wuhan Baishazhou Qingling Industrial Pharmaceutical Health Production Base
▲A map of Wuhan Baishazhou planning (platform exclusive)
It was learned from the Wuhan Planning Bureau that the Wuhan Hongqiang "Internet" + Pharmaceutical Health Production Base declared by Hubei Hongqiang Pharmaceutical Health Industry Co., Ltd. is located east of Nanjiao West Road, south of Jianyang Third Road, west of Wuhan University Science and Technology Park, and north of Xiwan Road, Hongshan District, Wuhan City.
▲Wuhan Baishazhou Hongqiang "Internet" + pharmaceutical health production base planning location
The plot introduces an "Internet +" pharmaceutical and health production base integrating health care products and Chinese patent medicine, medical device production and R&D, modern pharmaceutical trade, Internet e-commerce platform, and big health industry, and the industrial project is mainly used in the field of Chinese patent medicine production.
▲Wuhan Baishazhou Hongqiang "Internet" + pharmaceutical health production base planning location
▲Wuhan Baishazhou Hongqiang "Internet" + pharmaceutical health production base planning location
▲Wuhan Baishazhou Hongqiang "Internet" + pharmaceutical health production base planning location
Qingling New Town, the south gate of Wuhan Baishazhou
P(2023) No. 085 land planning
Earlier Wuhan Land Auction reported: P(2023)085 plot is the reserve land of Hongshan District Land Consolidation and Reserve Center, located east of Nanjiao West Road, south of Jianyang 3rd Road, west of Wuhan University Science and Technology Park, and north of Xiwan Road (Phase I of D5 plot of Qingling Urban Industrial Park).
▲武汉白沙洲P(2023)083/P(2023)084/P(2023)085号地块规划
According to the letter of the Hongshan District People's Government on the opinions of the construction project of the D5 plot (phase I) project of Qingling Urban Industrial Park, it is planned to introduce an "Internet +" pharmaceutical and health production base integrating health care products and Chinese patent medicine, medical device production and research and development, modern pharmaceutical trade, Internet e-commerce platform and big health industry, which is mainly used in the field of Chinese patent medicine production.
▲武汉白沙洲P(2023)083/P(2023)084/P(2023)085号地块规划
The plot ratio of the project is controlled between 2.0-3.0, the self-holding rate is 100%, and after the completion and production, the investment intensity of fixed assets is not less than 5 million yuan/mu, the land output rate is not less than 5 million yuan/(mu·year), the tax is not less than 500,000 yuan/(mu·year), and the construction period is 24 months.
▲武汉白沙洲P(2023)083/P(2023)084/P(2023)085号地块规划
P(2023) No. 085 plot information, bidder: Hubei Hongqiang Pharmaceutical Health Industry Co., Ltd., starting price: 42.2 million yuan, starting floor price: 278.38 yuan / square meter, transfer area: 50,530.8 square meters, construction area: 151592 square meters, land use: industrial, plot location: east of Nanjiao West Road, Hongshan District, south of Jianyang Third Road, west of Wuhan University Science and Technology Park, north of Xiwan Road.
Qingling Urban Industrial Park P(2023) No. 085 plot ended in Wuhan Land Exchange Market Network public auction, No. 085 plot is located in Qingling Park D5 Phase I plot of about 75.8 acres, and was finally won by Hubei Hongqiang Pharmaceutical Health Industry Co., Ltd. with 42.2 million yuan.
The bidders of the No. 085 industrial plot are all related enterprises in the biomedical industry. Among them, Wuhan Guangweixing Technology Co., Ltd. is a newly established subsidiary of Ma Yinglong Pharmaceutical Group Co., Ltd., which was founded in 1582 A.D. and is a group enterprise integrating four major business sectors: pharmaceutical industry, health, medical services and pharmaceutical business.
The successful completion of this local auction has allowed high-quality enterprises such as Tianmeng Group, Ma Yinglong Group and Hongqiang Pharmaceutical to settle in Qingling Park one after another, injecting new impetus into the high-quality development of Qingling Area, and promoting the agglomeration and development of the leading strategic emerging industry of medicine and health in Qingling Area, and further optimizing the industrial structure, which is of great significance for strengthening the chain and extending the chain of the pharmaceutical and health industry chain in the park.